Back
Corporate News
Concord Biotech's API facility completes USFDA inspection
24-Jun-2025, 07:06
Concord Biotech has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at its API facility at Dholka from 28 April 2025 till 2 May 2025.
Concord Biotech has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at its API facility at Dholka from 28 April 2025 till 2 May 2025.
Powered by Capital Market - Live News